Springer Nature announced on April 1, 2026, that Alexandra Dambeck has decided to step down from her role as Chief Financial Officer and as a member of the Management Board to pursue a new external opportunity. Her specific end date in the fourth quarter of 2026 will be confirmed in due course, and she will remain in her role until then. The process of selecting and appointing a successor is already underway.
Frank Vrancken Peeters, CEO of Springer Nature, expressed his appreciation for Dambeck's contributions, stating: "I have very much enjoyed working with Alexandra and would like to thank her for her commitment, professionalism and dedication throughout her time at Springer Nature, including during our successful IPO. I wish her the very best in her future endeavours." Stefan von Holtzbrinck, Chair of the Supervisory Board, added: "I would like to express our thanks and gratitude to Alexandra for all she achieved during her time at Springer Nature. She leaves the company in a strong financial position and set up for future growth."
Springer Nature, headquartered in Berlin, London, and New York, is one of the world's leading research publishers, known for pioneering open research and publishing the largest number of journals and books. The company's platforms and services support researchers, health professionals, and educators globally. The departure of a key executive like Dambeck signals a period of transition, but the company's strong financial standing and ongoing search for a successor aim to ensure stability. The announcement underscores the importance of leadership continuity in maintaining the company's growth trajectory and market position. For more information about Springer Nature, visit about.springernature.com and follow @SpringerNature.
